Truist Securities analysts wrote that Medtronic and Johnson & Johnson could “be relegated to niche players” in surgical robotics.

MIM Software, which GE Healthcare acquired earlier this month, will work with Elekta to improve treatment planning and workflows.

J.P. Morgan analysts expect this week’s results to be “very good” following reports from J&J, Abbott and Intuitive Surgical.

After the FDA issued a public safety notice and sent Exactech a warning letter, the firm agreed to recall shoulder implants due to packaging issues.

Lumicell developed the technology to enable physicians to detect residual cancer in the breast cavity after surgery.

After J&J’s $13.1 billion purchase of Shockwave Medical, Moody’s analysts see the potential for other larger pick-ups “if interest rates substantially decrease.” ...

While Intuitive has already placed eight new surgical robots, executives cautioned system placements could be choppy in the coming months.

Anne Wojcicki wants to buy all outstanding shares of the DNA testing firm, which has seen its stock slump in recent years.

Bruker made an offer roughly two months after Nanostring filed for bankruptcy protection and said it may restructure.

Boston Scientific has recalled an agent used to block blood flow to specific vessels due to a safety problem that has been tied to seven injuries and two deaths, the Food and Drug Administration said ...